122 related articles for article (PubMed ID: 20223287)
1. The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.
Ordóñez-Morán P; Alvarez-Díaz S; Valle N; Larriba MJ; Bonilla F; Muñoz A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):355-61. PubMed ID: 20223287
[TBL] [Abstract][Full Text] [Related]
2. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
Ordóñez-Morán P; Larriba MJ; Pálmer HG; Valero RA; Barbáchano A; Duñach M; de Herreros AG; Villalobos C; Berciano MT; Lafarga M; Muñoz A
J Cell Biol; 2008 Nov; 183(4):697-710. PubMed ID: 19015318
[TBL] [Abstract][Full Text] [Related]
3. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
Aguilera O; Peña C; García JM; Larriba MJ; Ordóñez-Morán P; Navarro D; Barbáchano A; López de Silanes I; Ballestar E; Fraga MF; Esteller M; Gamallo C; Bonilla F; González-Sancho JM; Muñoz A
Carcinogenesis; 2007 Sep; 28(9):1877-84. PubMed ID: 17449905
[TBL] [Abstract][Full Text] [Related]
4. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.
Alvarez-Díaz S; Valle N; García JM; Peña C; Freije JM; Quesada V; Astudillo A; Bonilla F; López-Otín C; Muñoz A
J Clin Invest; 2009 Aug; 119(8):2343-58. PubMed ID: 19662683
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells.
Fernandez-Garcia NI; Palmer HG; Garcia M; Gonzalez-Martin A; del Rio M; Barettino D; Volpert O; Muñoz A; Jimenez B
Oncogene; 2005 Sep; 24(43):6533-44. PubMed ID: 16007183
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells.
González-Sancho JM; Larriba MJ; Ordóñez-Morán P; Pálmer HG; Muñoz A
Anticancer Res; 2006; 26(4A):2669-81. PubMed ID: 16886677
[TBL] [Abstract][Full Text] [Related]
9. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth.
Tong WM; Hofer H; Ellinger A; Peterlik M; Cross HS
Oncol Res; 1999; 11(2):77-84. PubMed ID: 10489163
[TBL] [Abstract][Full Text] [Related]
11. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression.
Yang Y; Li L; He H; Shi M; He L; Liang S; Qi J; Chen W
Exp Cell Res; 2022 Feb; 411(2):113004. PubMed ID: 34990618
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1 induces the dissolution of tight junctions in human renal proximal tubular cells: role of the RhoA/ROCK signaling pathway.
Zhang K; Zhang H; Xiang H; Liu J; Liu Y; Zhang X; Wang J; Tang Y
Int J Mol Med; 2013 Aug; 32(2):464-8. PubMed ID: 23722562
[TBL] [Abstract][Full Text] [Related]
13. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line.
Buitrago CG; Ronda AC; de Boland AR; Boland R
J Cell Biochem; 2006 Mar; 97(4):698-708. PubMed ID: 16215981
[TBL] [Abstract][Full Text] [Related]
14. Downstream components of RhoA required for signal pathway of superoxide formation during phagocytosis of serum opsonized zymosans in macrophages.
Kim JS; Kim JG; Jeon CY; Won HY; Moon MY; Seo JY; Kim JI; Kim J; Lee JY; Choi SY; Park J; Yoon Park JH; Ha KS; Kim PH; Park JB
Exp Mol Med; 2005 Dec; 37(6):575-87. PubMed ID: 16391519
[TBL] [Abstract][Full Text] [Related]
15. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells.
Pálmer HG; Sánchez-Carbayo M; Ordóñez-Morán P; Larriba MJ; Cordón-Cardó C; Muñoz A
Cancer Res; 2003 Nov; 63(22):7799-806. PubMed ID: 14633706
[TBL] [Abstract][Full Text] [Related]
16. Ginseng (Panax quinquefolius) attenuates leptin-induced cardiac hypertrophy through inhibition of p115Rho guanine nucleotide exchange factor-RhoA/Rho-associated, coiled-coil containing protein kinase-dependent mitogen-activated protein kinase pathway activation.
Moey M; Rajapurohitam V; Zeidan A; Karmazyn M
J Pharmacol Exp Ther; 2011 Dec; 339(3):746-56. PubMed ID: 21875949
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
20. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
